The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Weight decreased 25
Rituximab Adenoma benign 24
Rituximab Large intestine polyp 24
Rituximab Mucosal inflammation 24
Rituximab Raynaud's phenomenon 24
Rituximab Rectal haemorrhage 24
Rituximab Rectal polyp 24
Rituximab Seborrhoeic dermatitis 24
Rituximab Skin plaque 24
Rituximab Sternal fracture 24
Rituximab Tonsillitis 24
Rituximab Toothache 24
Rituximab Hyponatraemia 23
Rituximab Skin infection 23
Rituximab Coronary artery disease 22
RITUXIMAB Musculoskeletal pain 22
Rituximab Neutrophil count increased 22
Rituximab Pulmonary embolism 22
RITUXIMAB Syncope 22
Rituximab White blood cell count increased 22

Total Records: 1,104     Number of Pages: 56